Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
about
Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 MiceProtein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases.Polyglutamine spinocerebellar ataxias - from genes to potential treatments.Ion channel dysfunction in cerebellar ataxia.Oligonucleotide therapeutics in neurodegenerative diseases.Assisted delivery of antisense therapeutics in animal models of heritable neurodegenerative and neuromuscular disorders: a systematic review and meta-analysis.
P2860
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
@ast
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
@en
type
label
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
@ast
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
@en
prefLabel
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
@ast
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
@en
P2093
P2860
P1476
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
@en
P2093
Danielle Gattis
Gautam Rajpal
Hayley S McLoughlin
Henry L Paulson
Holly B Kordasiewicz
Ian T Dillingham
Kate G Blumenstein
Lauren R Moore
Maya Qutob
P2860
P304
P356
10.1016/J.OMTN.2017.04.005
P577
2017-04-12T00:00:00Z